CleanSpace Holdings Limited (CSX.AX)
AUD 0.42
(13.51%)
AUD 0.42
(13.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 2.76 Million AUD | 3.06% |
| 2023 | 2.68 Million AUD | 130.84% |
| 2022 | 1.16 Million AUD | -27.39% |
| 2021 | 1.6 Million AUD | -15.71% |
| 2020 | 1.9 Million AUD | -17.88% |
| 2019 | 2.31 Million AUD | 0.88% |
| 2018 | 2.29 Million AUD | 2.26% |
| 2017 | 2.24 Million AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.16 Million AUD | 2.25% |
| 2024 Q4 | 2.76 Million AUD | 0.0% |
| 2024 FY | 2.76 Million AUD | 3.06% |
| 2024 Q3 | 2.76 Million AUD | 0.8% |
| 2024 Q2 | 2.74 Million AUD | 0.0% |
| 2023 Q4 | 1.16 Million AUD | -65.43% |
| 2023 Q2 | 925.71 Thousand AUD | 0.0% |
| 2023 FY | 2.68 Million AUD | 130.84% |
| 2023 Q1 | 925.71 Thousand AUD | -20.39% |
| 2023 Q3 | 3.36 Million AUD | 263.4% |
| 2022 Q4 | 1.16 Million AUD | 0.0% |
| 2022 Q3 | 1.16 Million AUD | -16.03% |
| 2022 Q2 | 1.38 Million AUD | 0.0% |
| 2022 Q1 | 1.38 Million AUD | -13.53% |
| 2022 FY | 1.16 Million AUD | -27.39% |
| 2021 Q1 | 1.8 Million AUD | -22.7% |
| 2021 FY | 1.6 Million AUD | -15.71% |
| 2021 Q2 | 8717.00 AUD | -99.52% |
| 2021 Q4 | 1.6 Million AUD | 0.0% |
| 2021 Q3 | 1.6 Million AUD | 18272.69% |
| 2020 Q1 | - AUD | 0.0% |
| 2020 Q3 | 2.35 Million AUD | 0.0% |
| 2020 Q4 | 2.33 Million AUD | -0.61% |
| 2020 FY | 1.9 Million AUD | -17.88% |
| 2019 FY | 2.31 Million AUD | 0.88% |
| 2018 FY | 2.29 Million AUD | 2.26% |
| 2017 FY | 2.24 Million AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| 4DMedical Limited | 4.17 Million AUD | 33.752% |
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 53.106% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | -80.909% |
| Control Bionics Limited | 336.16 Thousand AUD | -722.963% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 98.631% |
| Cyclopharm Limited | 4.01 Million AUD | 31.058% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | -56.615% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 77.756% |
| ImpediMed Limited | 810 Thousand AUD | -241.545% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.74 Million AUD | -58.721% |
| Micro-X Limited | 65 Thousand AUD | -4156.174% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | -272.845% |
| Respiri Limited | - AUD | -Infinity% |
| SomnoMed Limited | 709.07 Thousand AUD | -290.159% |
| Universal Biosensors, Inc. | 3.22 Million AUD | 14.235% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |